
Research Square (Research Square), Journal Year: 2024, Volume and Issue: unknown
Published: Oct. 21, 2024
Language: Английский
Research Square (Research Square), Journal Year: 2024, Volume and Issue: unknown
Published: Oct. 21, 2024
Language: Английский
Frontiers in Oncology, Journal Year: 2023, Volume and Issue: 13
Published: Aug. 15, 2023
Neoadjuvant anthracycline-based chemotherapy (NAC) is a major regimen for the treatment of local advanced breast cancer (LABC), while resistance to NAC remains paramount clinical obstacle. To investigate role heat shock protein 27 (Hsp27) and/or topoisomerase IIα (TopoIIα) in LABC patients treated with NAC, we performed this retrospective study. Associations Hsp27 transcripts clinic-pathological characteristics, survival and drug response were investigated public databases. Hsp27-related genes identified, followed by functional enrichment analyses. Besides, two protein-protein interaction networks built. Then, tumors from 103 who diagnosed received collected, TopoIIα examined Immunohistochemistry (IHC). Chi-square or Fisher's exact tests performed, as well Either at transcriptional level databases tested IHC, high was associated aggressive tumor characteristics such lymph node invasion resistance. mostly involved metabolic pathway gamete generation biological process. An elevated indicated poor prognosis (log-rank test P = 0.002 0.004 disease-free [DFS] overall [OS], respectively), it might not be an independent predictor. Of note, expression (TopoIIα+) less likely express (Hsp27+), contrast those negativity (31.1% vs. 86.2%, P<0.001), analyses revealed that Hsp27+ TopoIIα- had significantly lower DFS OS < 0.001 0.001, other three groups. cancers more predictable when concomitantly considering expression.
Language: Английский
Citations
2Biomedicines, Journal Year: 2024, Volume and Issue: 12(1), P. 109 - 109
Published: Jan. 4, 2024
The progression and maintenance of cancer characteristics are associated with cellular components linked to the tumor non-cellular pro-tumoral properties. Pharmacological association antagonists tumor, such as anti- pro-apoptotic drugs, represents a novel adjuvant strategy. In this study, antiproliferative, pro-apoptotic, pharmacological effects combination monophosphoester 2-AEH2P Simvastatin, Coenzyme Q10, chemotherapeutic drug paclitaxel, colony-stimulating factor (GM-CSF) were evaluated. Tests conducted determine cytotoxic activity using MTT method, cell cycle phases, fragmented DNA by flow cytometry, mitochondrial membrane potential, expression markers Bcl2, TNF-α/DR-4, Cytochrome c, caspase 3, P53, analysis profiles Synergy Finder 2.0 Software. results showed synergistic effect among combinations, compared individual treatments other drugs. addition, there was modulation marker expression, indicating immunomodulatory 2-AEH2P. revealed that cells treated GM-CSF + exhibited effect, while groups Simvastatin additive effects. Furthermore, treatment paclitaxel (12 h) resulted in significant reduction potential. combinations for normal did not exhibit deleterious mammary carcinomatosis (EAT) cells.
Language: Английский
Citations
0Frontiers in Oncology, Journal Year: 2024, Volume and Issue: 14
Published: Aug. 19, 2024
Background While Heat Shock Protein 60 (HSP60) has been linked to human tumor, its clinic significance specifically in breast carcinoma is unclear. This investigation aims retrospectively evaluate how HSP60 protein levels relate survival outcomes among patients diagnosed with carcinoma. Methods Evaluation of 206 and receiving treatment from January 2012 April 2018, carried out retrospectively. The level determined by immunohistochemical. Results study provided evidence a distinct upregulation expression tumor samples contrast adjacent normal tissue samples. Additionally, heightened was advanced T stage (P = 0.046), N 0.034), metastasis 0.016), pathological grading 0.012), adjuvant therapy utilization 0.004). Moreover, elevated proteins exhibited significant inverse correlation overall (OS) [hazard ratio (HR) 1.598, P 0.018] progression-free (PFS) (HR 1.600, 0.017) univariate analyses. results multivariate analyses highlighted may serve as an independent predictor for both OS PFS 1.525, 0.034; HR 1.528, 0.033, respectively). Conclusion involvement progression suggests potential clinical relevance target validation prognostic assessment the disease.
Language: Английский
Citations
0Materials Today Bio, Journal Year: 2024, Volume and Issue: 29, P. 101282 - 101282
Published: Sept. 30, 2024
Language: Английский
Citations
0Research Square (Research Square), Journal Year: 2024, Volume and Issue: unknown
Published: Oct. 21, 2024
Language: Английский
Citations
0